Activated platelets express P-selectin and release leukocyte chemoattractants; however, they have not been known to express integrin ligands important in the stabilization of leukocyte interactions with the vasculature. We now demonstrate the presence of intercellular adhesion molecular-2 (ICAM-2) (CD102), and lack of expression of other beta 2-integrin ligands, ICAM-1 (CD54) and ICAM-3 (CD50), on the surface of resting and stimulated platelets. ICAM-2 isolated from platelets migrates as a band of 59,000 M(r) in reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Staining of bone marrow aspirates with anti-ICAM-2 mAb demonstrates strong reactivity to megakaryocytes. Using frozen thin sections and immunogold labeling, the antigen was shown to be present on the plasma membrane and surface-connected canalicular system of resting platelets. The average number of ICAM-2 molecules per platelet is 3,000 +/- 230 and does not change after activation. In adhesion assays, resting and stimulated platelets were capable of binding through ICAM-2 to purified leukocyte function-associated antigen-1. Activation of T lymphocytes with PMA stimulated binding to platelets that was Mg2+ dependent and could be specifically inhibited by mAbs to either ICAM-2 or leukocyte function-associated antigen-1. ICAM-2 is the only known beta 2-integrin ligand present on platelets, suggesting that it may play an important role in leukocyte-platelet interactions in inflammation and thrombosis.
T G Diacovo, A R deFougerolles, D F Bainton, T A Springer
Title and authors | Publication | Year |
---|---|---|
Postprandial hyperglycemia as an etiological factor in vascular failure
K Node, T Inoue |
Cardiovascular Diabetology | 2009 |
Leukocyte - endothelial interactions in inflammation
HF Langer, T Chavakis |
Journal of Cellular and Molecular Medicine | 2009 |
Platelet membrane proteomics: a novel repository for functional research
U Lewandrowski, S Wortelkamp, K Lohrig, RP Zahedi, DA Wolters, U Walter, A Sickmann |
Blood | 2009 |
The formation of monocyte–platelet aggregates is independent of on-treatment residual agonists’-inducible platelet reactivity
T Gremmel, CW Kopp, D Seidinger, GA Giurgea, R Koppensteiner, S Steiner, S Panzer |
Atherosclerosis | 2009 |
Efalizumab-induced thrombocytopenia: report of relapse after re-administration
D Kiorpelidou, G Tsiouri, G Gaitanis, N Akritidis, ID Bassukas |
Clinical and Experimental Dermatology | 2009 |
The role of platelets in acute lung injury (ALI)
A Zarbock, K Ley |
Frontiers in bioscience : a journal and virtual library | 2009 |